Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class ASSE: 600276

Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program

· Issued by Jiangsu Hengrui Pharmaceuticals Co., Ltd. Class A via Shanghai Stock Exchange
Indicative Announcement on Acceptance of Application for Drug Marketing Authorization and Inclusion into the Priority Review Program

The abstract is for reference only. Please refer to the full text of the announcement on the very day.

Link of Full Text for Reference: View Attachment